CareSens N 30G lancets x 100

Product Information

Firmly insert a new lancet into the lancet holder. Hold the lancet firmly. Gently twist to pull off the protective disk. Save disk to recap lancet after use. Replace lancet device tip.

For your patients with diabetes who are currently prescribed Lantus ®: A step-by-step guide on how to use Lantus® SoloStar. Semaglutide is a biological medicine. Biological medicines must be prescribed and dispensed by brand name, see Biological medicines and Biosimilar medicines , under Guidance on Prescribing ; manufacturer advises to record the brand name and batch number after each administration. The CareSens N blood glucose monitor is designed to be easy to use; requiring only a small sample of blood, no coding required for the test strips and an easy to read display screen.

Prescribe by brand (Saxenda ®) to avoid patients inadvertently receiving a different product licensed for type 2 diabetes The use of Liraglutide for this indication is restricted to prescribing in secondary care by a specialist multidisciplinary Tier 3 weight management servicewith a commercial agreement in place. The CareSens N meter features a large display and no-skid rubber pads on the meter, so it’s easy to handle.

Training on the correct use, storage and recording of the readings should be provided by the issuing clinician When administration is with insulin: In line with NICE NG28, diabetes specialist initiation advice/recommendation should be sought when initiating GLP1 agonists in combination with insulin.Patients are required to wait at least 30 minutes before eating/drinking or taking other oral medicinal products. Waiting less than 30 minutes decreases absorption. For the treatment of patients with Type 2 diabetes who have nocturnal / severe hypoglycaemia or those with recurrent hypoglycaemic episodes requiring hospital admission Caution - retinopathy. Do not use in patients withpre-proliferative/proliferativeretinopathy (R2/R3 grade)or maculopathy (M1)or who are undergoing or awaiting eye laser or intravitreal treatments. Ensure all patients areup-to-date with theirretinopathy screening programmeprior to initiation of semaglutide, and thattheyattend their annual screening whilst on treatment.

Meal markers can be attached to tests to show which tests were pre-meal tests and which were post-meal tests. SLGT2 inhibitors are not to beused inprimary care for type 1 diabetes until further local guidance becomes available Insuman Comb 25 - Insuman® Comb 25 100 IU/mL- suspension for injection in a vial - Subcutaneous use.To avoid the use of an insulin pump in patients with Type 1 diabetes who have nocturnal/severe hypoglycaemia as defined in NICE TA 151 OR recurrent DKA despite good compliance with current insulin regime

NICE TA583: Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes

Sample loading – avoid spoiled tests

For your patients with diabetes who are currently prescribed Toujeo® SoloStar: A video on how to use Toujeo® SoloStar. MHRA: Canagliflozin (Invokana, Vokanamet): signal of increased risk of lower extremity amputations observed in trial in high cardiovascular risk patients You can use blood samples taken your fingertip, palm or forearm. A small sample of blood is required and your result is displayed in less than 5 seconds.